David Fiellin

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Measuring alcohol consumption using Timeline Followback in non-treatment-seeking medical clinic patients with and without HIV infection: 7-, 14-, or 30-day recall
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    J Stud Alcohol Drugs 74:500-4. 2013
  2. pmc A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    Am J Med 126:74.e11-7. 2013
  3. ncbi request reprint Guideline development for office-based pharmacotherapies for opioid dependence
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
    J Addict Dis 22:109-20. 2003
  4. doi request reprint Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
    Am J Addict 17:116-20. 2008
  5. ncbi request reprint Processes of care during a randomized trial of office-based treatment of opioid dependence in primary care
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520 8025, USA
    Am J Addict 13:S67-78. 2004
  6. ncbi request reprint Consensus statement on office-based treatment of opioid dependence using buprenorphine
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
    J Subst Abuse Treat 27:153-9. 2004
  7. ncbi request reprint Opioid dependence: rationale for and efficacy of existing and new treatments
    David A Fiellin
    Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Clin Infect Dis 43:S173-7. 2006
  8. ncbi request reprint Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06520, USA
    N Engl J Med 355:365-74. 2006
  9. doi request reprint Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone
    David A Fiellin
    Departments of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    J Acquir Immune Defic Syndr 56:S33-8. 2011
  10. ncbi request reprint Beyond diagnosis: patient mix and challenges to patient care in ambulatory training sites
    D A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Am J Med Sci 319:106-10. 2000

Detail Information

Publications69

  1. pmc Measuring alcohol consumption using Timeline Followback in non-treatment-seeking medical clinic patients with and without HIV infection: 7-, 14-, or 30-day recall
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    J Stud Alcohol Drugs 74:500-4. 2013
    ..Daily estimation measures such as the Timeline Followback (TLFB) have been validated, yet the optimal time window and its performance in non-treatment-seeking medical clinic subjects and among those with HIV are not known...
  2. pmc A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    Am J Med 126:74.e11-7. 2013
    ..To determine the impact of cognitive behavioral therapy on outcomes in primary care, office-based buprenorphine/naloxone treatment of opioid dependence...
  3. ncbi request reprint Guideline development for office-based pharmacotherapies for opioid dependence
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
    J Addict Dis 22:109-20. 2003
    ..We outline the process and describe the two guidelines that were produced by this process that are targeted at physicians, narcotic treatment programs, and policy makers...
  4. doi request reprint Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
    Am J Addict 17:116-20. 2008
    ..Serum transaminases remained stable from baseline. No serious adverse events related to treatment occurred. We conclude that select opioid-dependent patients exhibit moderate levels of retention in primary care office-based treatment...
  5. ncbi request reprint Processes of care during a randomized trial of office-based treatment of opioid dependence in primary care
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520 8025, USA
    Am J Addict 13:S67-78. 2004
    ..Chart audits and mentoring should be considered as a mechanism to foster quality care. These processes of care are likely to require attention for treatment using methadone or buprenorphine...
  6. ncbi request reprint Consensus statement on office-based treatment of opioid dependence using buprenorphine
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
    J Subst Abuse Treat 27:153-9. 2004
    ....
  7. ncbi request reprint Opioid dependence: rationale for and efficacy of existing and new treatments
    David A Fiellin
    Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Clin Infect Dis 43:S173-7. 2006
    ..This review focuses on the neurobiological basis of opioid dependence, the rationale for methadone and buprenorphine treatments, and issues in prescribing these medications to patients with HIV infection...
  8. ncbi request reprint Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06520, USA
    N Engl J Med 355:365-74. 2006
    ..The optimal level of counseling and frequency of attendance for medication distribution has not been established for the primary care, office-based buprenorphine-naloxone treatment of opioid dependence...
  9. doi request reprint Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone
    David A Fiellin
    Departments of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    J Acquir Immune Defic Syndr 56:S33-8. 2011
    ..Buprenorphine/naloxone allows the integration of opioid dependence and HIV treatment...
  10. ncbi request reprint Beyond diagnosis: patient mix and challenges to patient care in ambulatory training sites
    D A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Am J Med Sci 319:106-10. 2000
    ..Educational experiences in ambulatory medicine vary by site. Purpose: To evaluate variations in patient mix and challenges in patient care at 3 ambulatory training sites...
  11. ncbi request reprint Screening for alcohol problems in primary care: a systematic review
    D A Fiellin
    Yale University School of Medicine, 333 Cedar St, PO Box 208025, New Haven, CT 06520 8025, USA
    Arch Intern Med 160:1977-89. 2000
    ..Primary care physicians can play a unique role in recognizing and treating patients with alcohol problems...
  12. ncbi request reprint Methadone maintenance in primary care: a randomized controlled trial
    D A Fiellin
    Yale University School of Medicine, 333 Cedar St, PO Box 208025, New Haven, CT 06520 8025, USA
    JAMA 286:1724-31. 2001
    ..Office-based care of stabilized methadone maintenance patients is a promising alternative but no data are available from controlled trials regarding this type of program...
  13. ncbi request reprint Treatment of heroin dependence with buprenorphine in primary care
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Am J Drug Alcohol Abuse 28:231-41. 2002
    ..Eleven patients (79%) were retained through the maintenance phase. We conclude that buprenorphine maintenance is feasible in a primary care setting...
  14. ncbi request reprint Clinical practice. Office-based treatment of opioid-dependent patients
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06520 8025, USA
    N Engl J Med 347:817-23. 2002
  15. ncbi request reprint New federal initiatives to enhance the medical treatment of opioid dependence
    David A Fiellin
    Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520 8025, USA
    Ann Intern Med 137:688-92. 2002
    ..This perspective describes these initiatives and their implications for internists...
  16. ncbi request reprint Risk for delirium tremens in patients with alcohol withdrawal syndrome
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
    Subst Abus 23:83-94. 2002
    ..8 (95% CI 4.36-460). Elevated blood pressure, prior complicated alcohol withdrawal and medical comorbidity, alone and in combination, are associated with an increased risk of delirium tremens...
  17. ncbi request reprint Coordination of medical care and opioid dependence treatment in primary care: a case report
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
    Subst Abus 24:43-6. 2003
  18. ncbi request reprint Substance use of disorders in HIV-infected patients: impact and new treatment strategies
    David A Fiellin
    Yale University School of Medicine, New Haven, CT, USA
    Top HIV Med 12:77-82. 2004
    ..This article summarizes a presentation by David A. Fiellin, MD, in March 2004 at the International AIDS Society-USA New York course...
  19. pmc Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients
    Emlyn S Jones
    Department of Internal Medicine, Section of General Internal Medicine, Yale University School of Medicine, 333 Cedar St, P O Box 208025, New Haven, CT, United States
    Drug Alcohol Depend 99:132-40. 2009
    ..We conclude that providing clinic-based methadone is least expensive. The price of buprenorphine accounts for a major portion of the difference in costs. For patients, office-based treatment may be less expensive...
  20. ncbi request reprint Faculty development in small-group teaching skills associated with a training course on office-based treatment of opioid dependence
    Jeffrey G Wong
    Yale University School of Medicine, USA
    Subst Abus 25:35-40. 2004
    ..Evaluation of the DATA-2000 training session small-group facilitators was uniformly positive. This faculty development workshop was successful in improving teaching skills for our small-group faculty facilitators...
  21. ncbi request reprint Provider satisfaction with office-based treatment of opioid dependence: a systematic review
    William C Becker
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Subst Abus 26:15-22. 2005
    ..New federal regulations allow for office-based treatment of opioid dependent patients with opioid agonist medication (e.g., buprenorphine). We sought to evaluate the literature on office-based physicians' acceptance of this practice...
  22. pmc Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients
    Brent A Moore
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    J Gen Intern Med 22:527-30. 2007
    ..Prescription opioid dependence is increasing, but treatment outcomes with office-based buprenorphine/naloxone among these patients have not been described...
  23. pmc Patient satisfaction with primary care office-based buprenorphine/naloxone treatment
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519 1187, USA
    J Gen Intern Med 22:242-5. 2007
    ..Factors associated with satisfaction among patients receiving primary care-based buprenorphine/naloxone are unknown...
  24. pmc Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review
    Jeanette M Tetrault
    Clinical Epidemiology Research Center, Department of Veterans Affairs Connecticut Healthcare System, West Haven Veterans Affairs Medical Center, 950 Campbell Avenue, West Haven, CT 06516, USA
    Arch Intern Med 167:221-8. 2007
    ....
  25. ncbi request reprint Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction
    Bridget A Martell
    Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
    Ann Intern Med 146:116-27. 2007
    ..The prevalence, efficacy, and risk for addiction for persons receiving opioids for chronic back pain are unclear...
  26. pmc Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone
    Emily A Wang
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
    J Gen Intern Med 25:670-4. 2010
    ..Behaviors associated with opioid dependence often involve criminal activity, which can lead to incarceration. The impact of a history of incarceration on outcomes in primary care office-based buprenorphine/naloxone is not known...
  27. pmc Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlates
    William C Becker
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, United States
    Drug Alcohol Depend 90:280-7. 2007
    ..Non-medical use of sedatives and tranquilizers carries risks including development of abuse/dependence. Such use may correlate with psychiatric symptoms...
  28. pmc Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
    J Subst Abuse Treat 35:87-92. 2008
    ..We conclude that primary-care-based buprenorphine/naloxone treatment is associated with decreased drug-related HIV risk, but additional efforts may be needed to address sex-related HIV risk when present...
  29. ncbi request reprint Gender and non-medical use of prescription opioids: results from a national US survey
    Jeanette M Tetrault
    Veterans Affairs Clinical Epidemiology Research Center, West Haven, CT, USA
    Addiction 103:258-68. 2008
    ..Gender differences exist regarding alcohol and illicit drug use disorders in the United States. Little is known about the gender-related factors associated with non-medical use of prescription opioids...
  30. ncbi request reprint Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates
    William C Becker
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, United States
    Drug Alcohol Depend 94:38-47. 2008
    ..Non-medical use of prescription opioids carries risks including development of abuse/dependence. Such use may correlate with psychiatric, medical, and substance use characteristics...
  31. pmc The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
    Am J Addict 19:53-8. 2010
    ..35%, p = .001). We conclude that both baseline and in-treatment cocaine use is associated with worse treatment outcomes in patients receiving office-based buprenorphine/naloxone and may benefit from targeted interventions...
  32. pmc Integrating buprenorphine treatment into office-based practice: a qualitative study
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519 1187, USA
    J Gen Intern Med 24:218-25. 2009
    ..Despite the availability and demonstrated effectiveness of office-based buprenorphine maintenance treatment (BMT), the systematic examination of physicians' attitudes towards this new medical practice has been largely neglected...
  33. pmc Brief intervention for hazardous and harmful drinkers in the emergency department
    GAIL D'ONOFRIO
    Section of Emergency Medicine, Yale University School of Medicine, New Haven, CT 06519, USA
    Ann Emerg Med 51:742-750.e2. 2008
    ..To determine the efficacy of emergency practitioner-performed brief intervention for hazardous/harmful drinkers in reducing alcohol consumption and negative consequences in an emergency department (ED) setting...
  34. pmc Narrative review: buprenorphine for opioid-dependent patients in office practice
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
    Ann Intern Med 148:662-70. 2008
    ..The different components of treatment; the role of the physician who provides this treatment; and the logistics of treating this growing, multifaceted patient population are also examined...
  35. ncbi request reprint Training HIV physicians to prescribe buprenorphine for opioid dependence
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 6520 8025, USA
    Subst Abus 27:13-8. 2006
    ..HIV physicians' concerns regarding interactions between buprenorphine and HAART need to be addressed in future training efforts...
  36. ncbi request reprint Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
    Clin Infect Dis 41:891-6. 2005
    ..This review addresses the introduction of buprenorphine, in terms of public health, policy, and clinical implications for HIV-infected patients and for HIV care providers...
  37. ncbi request reprint Buprenorphine for office-based practice: consensus conference overview
    Thomas R Kosten
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06516, USA
    Am J Addict 13:S1-7. 2004
    ..This opportunity has a three-year window, however, and a critical need will be to attract a sufficient number of physicians into prescribing buprenorphine/naloxone in order to allow our patients increased access to this treatment...
  38. ncbi request reprint Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Addiction 100:150-8. 2005
    ..To examine the role of expanded access to opioid agonist treatment as a means to decrease international HIV transmission...
  39. pmc Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department
    GAIL D'ONOFRIO
    Section of Emergency Medicine, Yale University School of Medicine, 464 Congress Avenue, Suite 260, New Haven, CT 06519, USA
    Acad Emerg Med 12:249-56. 2005
    ....
  40. ncbi request reprint The prevalence and impact of alcohol problems in major depression: a systematic review
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA
    Am J Med 118:330-41. 2005
    ..In addition, the literature focuses almost exclusively on patients with alcohol abuse or dependence in psychiatric inpatient settings, and excludes patients with less severe alcohol problems and primary care outpatient settings...
  41. ncbi request reprint The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, P O Box 208025, New Haven, CT 06520 8025, USA
    Drug Alcohol Depend 79:113-6. 2005
    ..Treatment outcomes with buprenorphine in a PCC do not vary based on history of prior methadone treatment...
  42. ncbi request reprint The case for routine HIV screening and impact of managed care
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    Am J Manag Care 16:S345-51. 2010
    ..Given the public health impact of HIV infection, federal and private partnerships should be considered to establish routine HIV screening practices...
  43. pmc The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
    J Acquir Immune Defic Syndr 56:S54-61. 2011
    ..Cocaine use is common in opioid-dependent HIV-infected patients, but its impact on treatment outcomes in these patients receiving buprenorphine/naloxone is not known...
  44. pmc Gambling: an addictive behavior with health and primary care implications
    Marc N Potenza
    Yale University School of Medicine, New Haven, CT 06519, USA
    J Gen Intern Med 17:721-32. 2002
    ....
  45. ncbi request reprint A randomized trial of primary intensive care to reduce hospital admissions in patients with high utilization of inpatient services
    William H Sledge
    Department of Psychiatry, Yale University School of Medicine, Yale New Haven Psychiatric Hospital, New Haven, Connecticut 06519, USA
    Dis Manag 9:328-38. 2006
    ..We were unable to detect a difference in hospital use or functional status, mental health function, or medication adherence among patients who require frequent hospital admissions using our intervention...
  46. ncbi request reprint Primary intensive care: pilot study of a primary care-based intervention for high-utilizing patients
    Karen E Brown
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06508, USA
    Dis Manag 8:169-77. 2005
    ..Patient and staff satisfaction was high, although the intervention was very difficult for the providers...
  47. pmc HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study
    Frederick L Altice
    Yale University School of Medicine, New Haven, CT, USA
    J Acquir Immune Defic Syndr 56:S22-32. 2011
    ..Having opioid dependence and HIV infection are associated with poor HIV-related treatment outcomes...
  48. doi request reprint Substance use in patients with sexually transmitted infections: results from a national U.S. survey
    Jeanette M Tetrault
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    Am J Addict 19:504-9. 2010
    ..A diagnosis of an STI should prompt clinicians to screen for substance use, in particular, alcohol abuse/dependence and marijuana use. ..
  49. ncbi request reprint A trial of integrated buprenorphine/naloxone and HIV clinical care
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Clin Infect Dis 43:S184-90. 2006
    ..We investigated the feasibility and efficacy of integrating buprenorphine, along with 2 levels of counseling, into HIV clinical care...
  50. ncbi request reprint Initial strategies for integrating buprenorphine into HIV care settings in the United States
    Lynn E Sullivan
    Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Clin Infect Dis 43:S191-6. 2006
    ....
  51. ncbi request reprint Hepatitis C and HIV infections: implications for clinical care in injection drug users
    Lynn E Sullivan
    Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520 8025, USA
    Am J Addict 13:1-20. 2004
    ..Providers caring for patients who are or were IDUs must be aware of the management of these diseases and make efforts to integrate their medical care with the treatment of their substance abuse...
  52. pmc Opioids, chronic pain, and addiction in primary care
    Declan T Barry
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    J Pain 11:1442-50. 2010
    ..Addressing these barriers to pain treatment will be crucial to improving pain management service delivery...
  53. ncbi request reprint Women and opioid dependence treatment: office-based versus opioid treatment program-based care?
    Emlyn S Jones
    Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
    Subst Abus 28:3-8. 2007
    ..Nonetheless office-based treatment may provide a solution for women concerned about anonymity, stigma, and the requirement of daily visits to a MMP...
  54. pmc The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines
    R Scott Braithwaite
    Department of Internal Medicine, Section of General Internal Medicine, Yale University School of Medicine and VA Connecticut Healthcare System, New Haven, Connecticut, USA
    Med Care 47:610-7. 2009
    ..Practice guidelines rarely consider comorbid illness, and resulting overuse of health services may increase costs without conferring benefit...
  55. pmc Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence
    Marek C Chawarski
    Yale University School of Medicine, New Haven, CT 06519, USA
    J Subst Abuse Treat 33:411-5. 2007
    ..3% were brought back attached to the skin) and that weekly sweat testing is less sensitive than weekly urine testing in detecting opiate use, suggest limited utility of sweat patch testing in outpatient clinical settings...
  56. ncbi request reprint Connecticut statewide addiction medicine/psychiatry grand rounds
    Mark L Kraus
    Yale University School of Medicine, New Haven, Conneticut, USA
    Conn Med 67:357-9. 2003
  57. ncbi request reprint Quality of care for acute myocardial infarction in elderly patients with alcohol-related diagnoses
    David A Fiellin
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8088, USA
    Alcohol Clin Exp Res 30:70-5. 2006
    ..We sought to determine whether elderly patients with alcohol-related diagnoses are less likely to receive standard indicators of quality care for acute myocardial infarction...
  58. pmc Depression symptoms and treatment among HIV infected and uninfected veterans
    Kristen Sueoka
    Yale University School of Medicine, New Haven, CT, USA
    AIDS Behav 14:272-9. 2010
    ..09, 95% CI 1.04, 4.24). Primary care and HIV providers were equally unlikely to treat active depressive symptoms. Treatment variation by race, site, and availability of a mental health provider, suggests targets for intervention...
  59. pmc Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort
    Traci C Green
    Division of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States
    Drug Alcohol Depend 110:208-20. 2010
    ..Findings have the potential to inform screening and intervention efforts in aging drug users with and without HIV...
  60. ncbi request reprint Evaluation of a combined online and in person training in the use of buprenorphine
    Erik W Gunderson
    Columbia University College of Physicians and Surgeon and New York State Psychiatric Institute, New York, NY, USA
    Subst Abus 27:39-45. 2006
    ..Overall, physicians preferred in person instruction and may benefit from additional experiential training and support after curriculum participation...
  61. ncbi request reprint Methadone syrup injection in Australia: a sentinel finding?
    David A Fiellin
    Addiction 98:385-6. 2003
  62. doi request reprint Opioid use disorder in the United States: insurance status and treatment access
    William C Becker
    Department of Internal Medicine, Philadelphia VAMC, Philadelphia, PA 19104, United States
    Drug Alcohol Depend 94:207-13. 2008
    ..In the United States, insurance status and rates of treatment for individuals with opioid use disorder are unknown...
  63. ncbi request reprint Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?
    Erik W Gunderson
    Columbia University College of Physicians and Surgeons, New York, New York, USA
    CNS Drugs 22:99-111. 2008
    ..OBOT is not a replacement for more structured, traditional models of care, but provides an additional opportunity to help address the tremendous public health impact of opioid dependence...
  64. doi request reprint Treatment of adolescent opioid dependence: no quick fix
    David A Fiellin
    JAMA 300:2057-9. 2008
  65. ncbi request reprint Mental health after deployment to Iraq or Afghanistan
    David A Fiellin
    JAMA 296:515; author reply 516. 2006
  66. ncbi request reprint Buprenorphine: effective treatment of opioid addiction starts in the office
    David A Fiellin
    Am Fam Physician 73:1513-4. 2006
  67. pmc Update in addiction medicine for the generalist
    Adam J Gordon
    Mental Illness Research, Education, and Clinical Center, University of Pittsburgh, Pittsburgh, PA, USA
    J Gen Intern Med 22:1190-4. 2007
  68. ncbi request reprint Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans
    Kevin L Kraemer
    Center for Research on Health Care, Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    Med Care 44:S44-51. 2006
    ..Although alcohol problems are common in human immunodeficiency virus (HIV)-infected patients, their impact on health care services use in HIV-infected patients is not well understood...
  69. ncbi request reprint The association between marijuana smoking and lung cancer: a systematic review
    Reena Mehra
    Department of Medicine, Case Western Reserve University, Cleveland, Ohio 44106 6003, USA
    Arch Intern Med 166:1359-67. 2006
    ..Our objective was to assess the impact of marijuana smoking on the development of premalignant lung changes and lung cancer...

Research Grants9

  1. Counseling for Primary Care Office-Based Buprenorphine
    David Fiellin; Fiscal Year: 2007
    ..The results of this study will help define the role of professional evidence-based drug counseling in expanding access to treatment with Bup. ..
  2. Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence
    David Fiellin; Fiscal Year: 2007
    ..Relevance to public health: The results of this study will help define the role of maintenance vs. detoxification with buprenorphine in the care of prescription opioid dependent patients in primary care. ..
  3. Counseling for Primary Care Office-Based Buprenorphine
    David Fiellin; Fiscal Year: 2009
    ..The results of this study will help define the role of professional evidence-based drug counseling in expanding access to treatment with Bup. ..
  4. Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence
    David Fiellin; Fiscal Year: 2010
    ..Relevance to public health: The results of this study will help define the role of maintenance vs. detoxification with buprenorphine in the care of prescription opioid dependent patients in primary care. ..